Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients

AIMS: Routine, intermittent inotropic therapy (IIT) is still applied in advanced heart failure (HF) patients either as a bridge to definitive treatment or as a mean to improve quality of life (QOL), despite limited evidence to support its' use. Given recent reports of improved QOL and reduced H...

Descripción completa

Detalles Bibliográficos
Autores principales: Milwidsky, Assi, Frydman, Shir, Laufer‐Perl, Michal, Sadeh, Ben, Sapir, Orly, Granot, Yoav, Hochstadt, Aviram, Korotetski, Liuba, Ketchker, Liora, Topilsky, Yan, Banai, Shmuel, Havakuk, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934941/
https://www.ncbi.nlm.nih.gov/pubmed/35083882
http://dx.doi.org/10.1002/ehf2.13807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934941/
https://www.ncbi.nlm.nih.gov/pubmed/35083882
http://dx.doi.org/10.1002/ehf2.13807

Ejemplares similares